Upload
Featured Recent Articles Topics Login Upload

Search Results for 'treatment ibrutinib'

treatment ibrutinib published presentations and documents on DocSlides.

Ibrutinib: Analysis of Pivotal Data
Ibrutinib: Analysis of Pivotal Data
by alida-meadow
Richard R. Furman, MD. CLL Research Center. BCR-a...
Ibrutinib for Hairy Cell Leukemia
Ibrutinib for Hairy Cell Leukemia
by pasty-toler
. A Brief Update of an Ongoing Trial. Jeff Jones...
CLL: clinical cases Celso Arrais
CLL: clinical cases Celso Arrais
by genevieve
Conflict of Interests. I declare NO relevant confl...
Module 3: Chronic Lymphocytic Leukemia
Module 3: Chronic Lymphocytic Leukemia
by CottonTails
Josie . Montegaard. , MSN, AGPCNP-BC. Matthew S . ...
2022 Spring Oncology Conference
2022 Spring Oncology Conference
by byrne
Evolving Treatment Strategies. for CLL/SLL and MCL...
Btk inhibition in Mantle cell Lymphoma & CLL
Btk inhibition in Mantle cell Lymphoma & CLL
by test
Simon Rule. Professor of Clinical . Haematology. ...
Randomized Phase III
Randomized Phase III
by marina-yarberry
RESONATE . (PCYC-1112) Trial of Ibrutinib Compare...
Chronic lymphocytic leukemia,
Chronic lymphocytic leukemia,
by natalia-silvester
New agents timing?. Agne Paner, MD. Assistant pro...
Research To Practice ASH 2022 CLL Updates
Research To Practice ASH 2022 CLL Updates
by erica
John N. Allan. Associate Professor of Clinical Med...
uidelines
uidelines
by stella
Pan - London Haemato - O ncology Clinical G Lymph...
First Prospective Data on Minimal Residual Disease (MRD) Outcomes After Fixed-Duration Ibrutinib P
First Prospective Data on Minimal Residual Disease (MRD) Outcomes After Fixed-Duration Ibrutinib P
by mia
Ibr+Ven. ) Versus Chlorambucil Plus Obinutuzumab (...
Integration of Novel Therapies in WM and CLL : When and How
Integration of Novel Therapies in WM and CLL : When and How
by giovanna-bartolotta
Neil E Kay, M.D.. October 2014. Mayo Team. Deb Bo...
Mantelcell
Mantelcell
by tawny-fly
. lymfom. Från. indolent till aggressive . sju...